Targeted Medical Pharma Inc

Type: Company
Name: Targeted Medical Pharma Inc
Nationality: United States
Web Address: http://www.tmedpharma.com/
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Targeted Medical Pharma: Trial Results Confirm Theramine More Effective Than Ibuprofen in Reducing Low Back Pain

Targeted Medical Pharma has reported the results of a second, double-blind clinical trial which confirmed that Theramine was shown not only to be more effective than ibuprofen in reducing low back pain, but also demonstrated a significant reduction in ... [Published Individual.com - Sep 26 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 3 reports

Clinical Trial Results Confirm the Amino Acid Based Medical Food Theramine® is more Effective at Improving Chronic Back Pain than NSAID Pain Medications

LOS ANGELES--(EON: Enhanced Online News)--Targeted Medical Pharma (OTCQB:TRGM) releases new clinical trial data for the medical food Theramine, showing that it is more effective than NSAIDs at managing chronic low back pain. ... [Published EON Science - Sep 23 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

Targeted Medical Pharma to Present at Sachs Associated 14th Annual Biotech in Europe Forum for Global Partnering and Investment

10:00 AM Eastern Daylight TimeLOS ANGELES--( BUSINESS WIRE )-- TargetedMedical Pharma (OTCQB:TRGM), today announced that William Shell,M.D., Chairman, CSO and CEO is scheduled to present the latest companyinformation regarding the advances in therape ... [Published Business Wire - Sep 16 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Vista Partners Brings Out September 2014 Macroeconomic & Investment Newsletter

Vista Partners published its free Macroeconomic & Investment Monthly Newsletter for the month of September. According to a release from the Company, each monthly newsletter from Vista contains macroeconomic thoughts from Principal Analyst Ross Silver, ... [Published Individual.com - Sep 11 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

SPDR S& 500 ETF : Vista Partners Publishes September 2014 Macroeconomic & Investment Newsletter

- Vista Partners ("Vista") published its FREE Macroeconomic & Investment Monthly Newsletter for the month of September. Each monthly newsletter from Vista contains macroeconomic thoughts from Principal Analyst Ross Silver, investment considerations, monthly ... [Published 4 Traders - Sep 05 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 2 reports

Investment Fraudster Who Targeted Medical Professionals Pleads Guilty

It’s an age-old scam: A smooth-talking individual offers an amazing investment opportunity—with promises of large returns—that turns out to be completely bogus. But because there are always people willing to accept these kinds of claims at face value ... [Published FBI - Aug 26 2014]
First reported Aug 14 2014 - Updated Aug 15 2014 - 1 reports

Targeted Medical Pharma Reports Second Quarter 2014 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB: TRGM) Reports promising Q2 2014 financial results. The company showed significant improvements in revenue, gross profit, and adjusted EBITDA compared to Q2 2013. ... [Published Business Wire Health News - Aug 14 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 2 reports

Targeted Medical Pharma Agrees to Sponsor a Clinical Trial Conducted by the United States Army and Henry M. Jackson Foundation for the Advancement of Military Medicine

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma and the United States Army announce the initiation of a clinical trial for the use of Theramine for the treatment of low back pain among active service members. ... [Published Business Wire Defense News - Jul 28 2014]
First reported Jun 12 2014 - Updated Jun 12 2014 - 1 reports

Targeted Medical Pharma Appoints Two New Independent Members to the Board of Directors

LOS ANGELES--(BUSINESS WIRE)--Kerry Weems and Paul Pelosi Jr. join the Targeted Medical Pharma (OTCQB:TRGM) board of directors. ... [Published Business Wire Health News - Jun 12 2014]
First reported May 22 2014 - Updated May 22 2014 - 3 reports

Targeted Medical Pharma Looks to China as the Next Medical Food Market

LOS ANGELES--(EON: Enhanced Online News)--Targeted Medical Pharma (OTCQB:TRGM) looks to China as the next major medical foods market. ... [Published EON Retail - May 22 2014]
First reported May 22 2014 - Updated May 22 2014 - 1 reports

Targeted Medical Pharma Reports First Quarter 2014 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB: TRGM) announces 2014, first quarter financial results. ... [Published Business Wire Health News - May 22 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Targeted Medical Pharma Completes Middle East Distribution Agreement

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB:TRGM) finalizes a distribution contract for twenty countries in the Middle East, providing the company with a platform for international growth. ... [Published Business Wire Health News - Apr 17 2014]

Quotes

...on the black box warning associated with every NSAID product," said William Shell M D , cardiologist, CEO, and CSO at Targeted Medical Pharma. "The current recommendation of the American Geriatric Society is to restrict or eliminate the use of NSAIDs in patients 65 years of age and older due to their potential risks. The results of this and previous studies confirm that Theramine can be used as a safe and effective alternative to NSAIDs and potentially other dangerous pain medications for patients suffering from chronic pain."
In the September 2014 Macroeconomic & Investment Newsletter, Silver said, "According to 13F filings, billionaire George Soros has increased his total SPY Put (an option to sell the S&P 500 at a higher price assuming the S&P 500 price will decrease) to a new record high of $2.2 billion, or nearly double the previous all-time high, and a staggering 17 percent of his total assets under management. The 'Soros Put' as many call it, is a legacy hedge position that the 83-year old has been rolling over every quarter since 2010. What does this mean?"
...that by addressing the increased amino acid requirements of pain syndromes you can significantly improve pain perception and reduce inflammation. "Theramine is a very useful clinical tool for physicians interested in managing pain and inflammation without the GI or cardiovascular side effects associated with NSAIDs or the addictive potential of narcotics" Dr Shell added. Latest News
...about the side effects of drugs," said William Shell, M D CEO and Chief Science Officer of Targeted Medical PharmaTargeted Medical Pharma Inc. "This agreement will introduce this unique product into a broader marketplace, helping to build a sustainable sales channel for the dietary supplement division of the Company." Latest News

More Content

All (45) | News (8) | Reports (0) | Blogs (36) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Targeted Medical Pharma: Trial Results Confirm ... [Published Individual.com - Sep 26 2014]
Clinical Trial Results Confirm the Amino Acid B... [Published EON Science - Sep 23 2014]
Clinical Trial Results Confirm the Amino Acid B... [Published Business Wire Health News - Sep 23 2014]
Clinical Trial Results Confirm the Amino Acid B... [Published Business Wire Science: Science News - Sep 23 2014]
Targeted Medical Pharma to Present at Sachs Ass... [Published Business Wire - Sep 16 2014]
Targeted Medical Pharma to Present at Sachs Ass... [Published Business Wire Health News - Sep 16 2014]
Vista Partners Brings Out September 2014 Macroe... [Published Individual.com - Sep 11 2014]
SPDR S& 500 ETF : Vista Partners Publishes Sept... [Published 4 Traders - Sep 05 2014]
Investment Fraudster Who Targeted Medical Profe... [Published FBI - Aug 26 2014]
Investment Fraudster Who Targeted Medical Profe... [Published FBI Extra - Aug 26 2014]
Targeted Medical Pharma Reports Second Quarter ... [Published Business Wire Health News - Aug 14 2014]
Targeted Medical Pharma Agrees to Sponsor a Cli... [Published Business Wire Defense News - Jul 28 2014]
Targeted Medical Pharma Agrees to Sponsor a Cli... [Published Business Wire Health News - Jul 28 2014]
Tauriga Sciences Inc. Signs License Agreement W... [Published GlobeNewswire: Advertising News - Jul 16 2014]
Targeted Medical Pharma Appoints Two New Indepe... [Published Business Wire Health News - Jun 12 2014]
Targeted Medical Pharma Looks to China as the N... [Published EON Retail - May 22 2014]
Targeted Medical Pharma Looks to China as the N... [Published Business Wire Retail News - May 22 2014]
Targeted Medical Pharma Looks to China as the N... [Published Business Wire Health News - May 22 2014]
Targeted Medical Pharma Reports First Quarter 2... [Published Business Wire Health News - May 22 2014]
Targeted Medical Pharma Completes Middle East D... [Published Business Wire Health News - Apr 17 2014]
Targeted Medical Pharma launches e-prescribe pl... [Published Pharmaceutical Business Review - Mar 10 2014]
Targeted Medical completes promotion, distribut... [Published Pharmaceutical Business Review - Feb 12 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON Communications - Feb 10 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON: Enhanced Online News - Feb 10 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON Science - Feb 10 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON Transportation - Feb 10 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON Environment - Feb 10 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON Retail - Feb 10 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON Manufacturing - Feb 10 2014]
Targeted Medical Pharma Completes Promotion and... [Published EON Energy - Feb 10 2014]
1 2
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Clinical Trial Results Confirm the Amino Acid B... [Published EON Science - Sep 23 2014]
LOS ANGELES--(EON: Enhanced Online News)--Targeted Medical Pharma (OTCQB:TRGM) releases new clinical trial data for the medical food Theramine, showing that it is more effective than NSAIDs at managing chronic low back pain. ...
Clinical Trial Results Confirm the Amino Acid B... [Published Business Wire Health News - Sep 23 2014]
LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB:TRGM) releases new clinical trial data for the medical food Theramine, showing that it is more effective than NSAIDs at managing chronic low back pain. ...
Clinical Trial Results Confirm the Amino Acid B... [Published Business Wire Science: Science News - Sep 23 2014]
LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB:TRGM) releases new clinical trial data for the medical food Theramine, showing that it is more effective than NSAIDs at managing chronic low back pain. ...
Targeted Medical Pharma to Present at Sachs Ass... [Published Business Wire Health News - Sep 16 2014]
LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB:TRGM), is scheduled to present the latest in therapeutic nutrition and medical food at SACHS Associated 14th Annual Biotech Europe Forum in Basel, Switzerland. ...
Investment Fraudster Who Targeted Medical Profe... [Published FBI Extra - Aug 26 2014]
Con man pleads guilty to bilking dozens of medical professionals out of millions. ...
1 2 3 4 5 6 7 8

Press Releases

sort by: Date | Relevance
Tauriga Sciences Inc. Signs License Agreement W... [Published GlobeNewswire: Advertising News - Jul 16 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.